November 13, 2025 - 05:27

LANGHORNE, Pa., November 12, 2025—Savara Inc., a clinical stage biopharmaceutical company dedicated to addressing rare respiratory diseases, has announced its financial results for the third quarter ending September 30, 2025. The company continues to focus on developing innovative therapies aimed at improving the lives of patients suffering from these challenging conditions.
During the third quarter, Savara reported significant advancements in its clinical programs, which are designed to bring new treatment options to market. The company highlighted its commitment to research and development, emphasizing ongoing trials and collaborations aimed at enhancing its product pipeline.
Savara's leadership expressed optimism about the future, noting a strong financial position that enables continued investment in critical projects. The results reflect the company’s strategic focus on bringing novel therapies to patients and advancing its mission in the biopharmaceutical landscape. As Savara moves forward, it remains dedicated to its goal of transforming the treatment landscape for rare respiratory diseases.
March 17, 2026 - 05:38
Nvidia adds Hyundai, BYD and other automakers to self-driving tech businessNvidia has significantly bolstered its presence in the automotive sector by adding industry giants Hyundai, BYD, and several other leading automakers to its roster of partners for self-driving...
March 16, 2026 - 01:37
Bartlett Tree Experts expands with acquisition of Lee Gilman & AssociatesBartlett Tree Experts, the internationally recognized family-owned firm specializing in scientific arboriculture, has announced a significant expansion in southern New Hampshire. The company has...
March 15, 2026 - 06:20
DEA seizes $300K during search warrant at West LA businessFederal investigators executed a search warrant at a West Los Angeles business this week, resulting in a significant seizure of cash and illicit products. Authorities confiscated approximately $300...
March 14, 2026 - 21:40
Forbes Business Council Accepts Komodo Luxury Founder Agung Afif as MemberAgung Afif, the founder and CEO of the Bali-based yacht charter company Komodo Luxury, has been accepted into the prestigious Forbes Business Council. This invitation-only community is reserved for...